Currently Funded Research
-
R01 HL152973
July 01, 2021 - June 30, 2026
Title: Development of Novel Therapeutic Approaches for Treatment of Alveolar Capillary Dysplasia
NIH / NHLBI
-
R01 HL158659
July 01, 2021 - June 30, 2026
Title: Role of lung endothelial cells in development and progression of pulmonary fibrosis
NIH/NHLBI
-
DOD CDMRP 13685892-LC220104
January 06, 2023- May 30, 2025
Title: Decreasing Lung Tumor Progression through Transcriptional Reprogramming of Tumor-Associated Endothelial Cells.
Department of Defense
Completed Research
-
CancerFree KIDS Foundation
January 2023 - December 2023
Title: The sequential therapy of RCM-1 and anti-apoptotic BCL2 family protein inhibitors
CancerFree KIDS Foundation
-
Varian Medical Systems, Inc. Research Grant
April 01, 2017 - June 30, 2022
Title: Effect of FLASH proton radiation on Lung Cancer treatment and Pulmonary Toxicity/Fibrosis
Varian Medical Systems, Inc.
-
1R01 HL132849
September 2016 - August 2021
Title: Targeting FoxM1 in pulmonary fibrosis
NIH/NHLBI
-
CCHMC Innovation Fund
July 2018 - June 2019
Title: Pre-clinical development of RCM-1 compound
CCHMC
-
Research Scholar Grant RSG-13-325
September 2013 - August 2017
Title: Transcriptional Regulation of Cancer Progression and Metastasis
American Cancer Society
-
R56 HL126660
September 2015 - October 2016
Title: Transcriptional Regulation of Pulmonary Fibrosis
NIH/NHLBI
-
R01 CA142724
June 2010 - June 2015
Title: Role of Foxm1 in Lung Cancer Microenvironment
NIH/NCI
-
Department of Defense #PC080478
July 2009 - June 2012
Title: Initiation and Progression of Prostate Cancer
DOD
-
Concern Foundation
July 2008 - June 2010
Title: o Role of Inflammation during Formation of Lung Cancer
Concern Foundation
-
Institutional Research Grant #IRG-92-026-12
July 2008 - December 2008
American Cancer Society